Search research articles
Contact Us
Filters
Showing results (1-10 of 157) with videos related to
Page
of 16
Sort By:
Anticancer Research
|
December 17, 1998
The past, the present and future of the OK-432 therapy for patients with malignant effusions
M Katano, T Morisaki
Rinsho Byori. the Japanese Journal of Clinical Pathology
|
July 1, 1987
[Selection and understanding of bedside tests. Hematologic and hematopoietic symptoms]
T Morisaki, S Miwa
Clinical Immunology and Immunopathology
|
June 1, 1991
Enhanced adherence activity of OK-432-induced peritoneal neutrophils to tumor cells correlates to their increased expression of CD11b/CD18
T Morisaki, M Torisu
Molecular and Cellular Biology
|
September 1, 1993
Functionally distinct elements are required for expression of the AMPD1 gene in myocytes
T Morisaki, E W Holmes
Surgery
|
February 1, 1994
Immunologic assessment of host defense impairment in patients with septic multiple organ failure: relationship between complement activation and changes in neutrophil function
T Goya, T Morisaki, M Torisu
The Japanese Journal of Surgery
|
March 1, 1989
A case of a postoperative aneurysm of the common hepatic artery which ruptured into the remnant stomach after a radical gastrectomy
H Satoh, T Morisaki, H Kishikawa
Immunology
|
September 1, 1991
Evidence that induction and regulation of lymphokine-activated killer (LAK) activity are mediated by changes in tumour-binding potential of lymphocytes after activation by interleukin-2 (IL-2)
A Uchiyama, T Morisaki, M Torisu
Nihon Rinsho. Japanese Journal of Clinical Medicine
|
August 1, 1985
[Congenital hemolytic jaundice]
T Morisaki, H Fujii, S Miwa
American Journal of Hematology
|
May 1, 1985
Adenosine deaminase (ADA) in leukemia: clinical value of plasma ADA activity and characterization of leukemic cell ADA
T Morisaki, H Fujii, S Miwa
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology
|
November 1, 1985
[Clinical significance of plasma adenosine deaminase (ADA) activity in leukemia]
T Morisaki, H Fujii, S Miwa
Page
of 16
Search research articles
Search
Showing results (1-10 of 157) with videos related to
Sort By:
Page
of 16
Anticancer Research
|
December 17, 1998
The past, the present and future of the OK-432 therapy for patients with malignant effusions
M Katano, T Morisaki
Rinsho Byori. the Japanese Journal of Clinical Pathology
|
July 1, 1987
[Selection and understanding of bedside tests. Hematologic and hematopoietic symptoms]
T Morisaki, S Miwa
Clinical Immunology and Immunopathology
|
June 1, 1991
Enhanced adherence activity of OK-432-induced peritoneal neutrophils to tumor cells correlates to their increased expression of CD11b/CD18
T Morisaki, M Torisu
Molecular and Cellular Biology
|
September 1, 1993
Functionally distinct elements are required for expression of the AMPD1 gene in myocytes
T Morisaki, E W Holmes
Surgery
|
February 1, 1994
Immunologic assessment of host defense impairment in patients with septic multiple organ failure: relationship between complement activation and changes in neutrophil function
T Goya, T Morisaki, M Torisu
The Japanese Journal of Surgery
|
March 1, 1989
A case of a postoperative aneurysm of the common hepatic artery which ruptured into the remnant stomach after a radical gastrectomy
H Satoh, T Morisaki, H Kishikawa
Immunology
|
September 1, 1991
Evidence that induction and regulation of lymphokine-activated killer (LAK) activity are mediated by changes in tumour-binding potential of lymphocytes after activation by interleukin-2 (IL-2)
A Uchiyama, T Morisaki, M Torisu
Nihon Rinsho. Japanese Journal of Clinical Medicine
|
August 1, 1985
[Congenital hemolytic jaundice]
T Morisaki, H Fujii, S Miwa
American Journal of Hematology
|
May 1, 1985
Adenosine deaminase (ADA) in leukemia: clinical value of plasma ADA activity and characterization of leukemic cell ADA
T Morisaki, H Fujii, S Miwa
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology
|
November 1, 1985
[Clinical significance of plasma adenosine deaminase (ADA) activity in leukemia]
T Morisaki, H Fujii, S Miwa
Page
of 16